Crossmark

Integrative research and innovation strategy for rare diseases. Insights from the 5-year European joint programme on rare diseases, including analysis to inform recommendations for future actions

Crossref DOI link: https://doi.org/10.1186/s12961-025-01389-7

Published Online: 2025-10-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sánchez-González, María del Carmen

Sarmiento-Suárez, Rodrigo

Cellai, Laura Lee

Moreau, Clément

Bartoszewicz, Marcin

Fiedor, Piotr

Taruscio, Domenica

de Santis, Marta

Posada de la Paz, Manuel

Julkowska, Daria

Carta, Claudio

Bermejo-Sánchez, Eva
Funding

Funding for this research was provided by:

European Commission (GA no. 825575)
License Information

Text and Data Mining valid from 2025-10-16

Version of Record valid from 2025-10-16
More Information

Article History

Received: 12 August 2024

Accepted: 14 August 2025

First Online: 16 October 2025

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below